Literature DB >> 7206770

Hemodynamic evaluation of the St. Jude Medical valve prosthesis in the small aortic anulus.

D C Wortham, T B Tri, T E Bowen.   

Abstract

The hemodynamic function of the 19 mm and 21 mm St. Jude Medical valve prostheses in the aortic position was evaluated in seven patients who had valve replacement for either severe aortic stenosis or regurgitation an average of 4 months after operation. Cardiac output and simultaneous transvalvular gradient were recorded at rest and during moderate supine arm exercise. The average peak systolic gradient was 14 mm Hg (range 0 to 25 mm Hg) at rest and 32 mm Hg (range 23 to 56 mm Hg) with exercise. The average mean systolic gradient was 20 mm Hg (range 10 to 28 mm Hg) at rest and 38 mm Hg (range 30 to 48 mm Hg) with exercise. The mean effective orifice area was 1.2 cm2 (range 0.9 to 1.4 cm2) at rest and 1.1 cm2 (range of 0.9 to 1.3 cm2) with exercise. Mean cardiac output at rest was 4.4 L/min, and, with exercise, 7.4 L/min. Of the five valves evaluated with root aortography, four demonstrated trivial and one mild aortic insufficiency. We conclude that the St. Jude Medical valve prostheses in the aortic position has favorable hemodynamic function which is particularly evident in the 19 mm and 21 mm sizes when compared with other currently available aortic valve prostheses.

Entities:  

Mesh:

Year:  1981        PMID: 7206770

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

1.  Left ventricular mass index reduction early after an isolated aortic valve replacement with St. Jude Medical 19A-HP.

Authors:  Shin Uchikawa; Shigeyuki Aomi; Akihiko Kawai; Kenji Yamazaki; Yasuko Tomizawa; Hiroshi Nishida; Masahiro Endo; Hitoshi Koyanagi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-08

2.  Open-heart surgery at the Texas Heart Institute: the first 50,000 operations.

Authors:  D A Cooley
Journal:  Tex Heart Inst J       Date:  1983-06

3.  A nineteen-millimetre aortic valve prosthesis: is this really a risk?

Authors:  P Lipiec; L Noyez; R M H J Brouwer
Journal:  Neth Heart J       Date:  2001-11       Impact factor: 2.380

4.  Systemic atrioventricular valve replacement in an infant.

Authors:  R E Ringel; A L Moulton; J I Brenner; M A Berman
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

5.  Aortic and mitral valve replacement with the St. Jude Medical prosthesis.

Authors:  F A Crawford; J M Kratz; R M Sade; M R Stroud; D M Bartles
Journal:  Ann Surg       Date:  1984-06       Impact factor: 12.969

Review 6.  Bioengineering aspects of heart valve replacement.

Authors:  F J Schoen; J L Titus; G M Lawrie
Journal:  Ann Biomed Eng       Date:  1982       Impact factor: 3.934

7.  Five-year clinical evaluation of the St. Jude Medical valve prosthesis in 136 patients.

Authors:  K Koja; A Kusaba; I Yara; M Kina; T Uesato; Y Kuniyoshi; K Iha
Journal:  Jpn J Surg       Date:  1985-05

8.  Aortic valve replacement with 31- and 33-mm mechanical prostheses: early results.

Authors:  Gaurav Gupta; Ambuj Roy; A Sampath Kumar
Journal:  Tex Heart Inst J       Date:  2004
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.